It seemed unfortunate timing for Oss-based biotech company RiboPro to launch its business on the eve of the corona crisis. But it turned out to be a winning move.
Try to think of covid as a newborn child that needs to be raised. Our columnist Helen Kardan thinks about and reflects on what parenting this baby should entail.
Data journalist Jelmer Visser makes real-world sense of the corona pandemic in Europe. This week: How did the British, Americans and Israelis come by so many vaccines?
elmer Visser outlines the spread of the corona pandemic in Europe for Innovation Origins. This week: Why the British are vaccinating at full speed and EU countries aren’t.
Jelmer Visser interprets for Innovation Origins the spread of the corona pandemic in Europe. This week: Where are countries one month after V Day?
For Innovation Origins, Jelmer Visser clarifies the corona pandemic in Europe This week: What are the experiences with curfews and is the Netherlands starting to catch up on its vaccine backlog?
Jelmer Visser tracks for Innovation Origins the movements of the coronary pandemic in Europe. This week: which countries score best (and worst) in vaccinating their population?
Apart from a lot of misery, the corona crisis also yields plenty of new insights into the treatment of other diseases.
AstraZeneca and Moderna have presented the interim results of their Phase 3 research. After a long wait, there are now three vaccines in sight instead of one.
Italy is considering transporting future corona vaccines by drone. A trial this week went very smoothly.
The German Paul Ehrlich Institute (PEI) is confident that a vaccine against the novel SARS CoV-2 coronavirus could be available by the end of 2020.
Update: USA won’t get Corona vaccine via takeover: “Europe is not for sale” – CureVac gets €80 million from EU
One day after we wrote this article (see below) about the fact that biotechnology company Curevac and major shareholder Dietmar Hopp said “no” to a […]
The Cytuvax vaccine for so-called non-responders to Hepatitis B vaccinations has helped more than one hundred physicians in clinical trials. “About 5 % of the […]
Over the past twenty years, nanoparticles have played an increasingly important role in medicine. They are used in drugs, e.g. for diseases such as Parkinson’s […]